Veradermics Inc
MANE
81 hedge funds and large institutions have $1.64B invested in Veradermics Inc in 2026 Q1 according to their latest regulatory filings, with 81 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
74.03% more ownership
Funds ownership: 0% → 74.03% (+74%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
+$210M |
| 2 |
SOCM
SR One Capital Management
Wayne,
Pennsylvania
|
+$121M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$92.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$90.4M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$85.3M |
Top Sellers
MANE Hedge Fund Activity: Q1 2026 in Review
81 of the 8,206 institutional investors tracked by Wall St. Rank reported a position in Veradermics Inc (MANE) for Q1 2026, worth a combined $1.64B.
Buyers outnumbered sellers: 81 funds opened new MANE positions and 0 closed out — a net gain of 81 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Suvretta Capital Management, opening a new position worth an estimated $210M.
- 81 institutional investors held Veradermics Inc (MANE) as of Q1 2026, up from 0 in Q4 2025.
- Funds reported $1.64B of Veradermics Inc stock for Q1 2026.
- 81 funds opened new Veradermics Inc positions in Q1 2026 and 0 closed out, a net change of +81 holders.
- The largest Veradermics Inc buyer in Q1 2026 was Suvretta Capital Management, an estimated $210M added.
Based on aggregated 13F filings for Q1 2026.